Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dan Calvo, Erik Wallden

Premium

Gyros has appointed Dan Calvo to serve as president and CEO. He replaces Erik Walldén, who had served in the same roles since 2009.

Calvo previously served as president and CEO of Oncoimmune USA. He held the same positions at Assay Designs and Cellomics. Oncoimmune USA, Assay Designs, and Cellomics have since been acquired by Health Discovery Lab, Enzo Biochem, and Thermo Fisher, respectively.

Uppsala, Sweden-based Gyros sells a microfluidics-based platform for performing immunoassays.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.